{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T23:23:46Z","timestamp":1778196226613,"version":"3.51.4"},"reference-count":164,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2014,9,9]],"date-time":"2014-09-09T00:00:00Z","timestamp":1410220800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Gynecol Obstet"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1007\/s00404-014-3433-z","type":"journal-article","created":{"date-parts":[[2014,9,8]],"date-time":"2014-09-08T07:46:49Z","timestamp":1410162409000},"page":"1079-1092","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Focus on metabolic and nutritional correlates of polycystic ovary syndrome and update on nutritional management of these critical phenomena"],"prefix":"10.1007","volume":"290","author":[{"given":"Mariangela","family":"Rondanelli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simone","family":"Perna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Milena","family":"Faliva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca","family":"Monteferrario","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erica","family":"Repaci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca","family":"Allieri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,9,9]]},"reference":[{"key":"3433_CR1","first-page":"2434","volume":"85","author":"AM Calvo","year":"2000","unstructured":"Calvo AM, San Millan RM, Sancho JL, Avila SJ, Escobar-Morreale HF (2000) A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain. J Clin Endocrinol Metab 85:2434\u20132438","journal-title":"J Clin Endocrinol Metab"},{"key":"3433_CR2","first-page":"774","volume":"18","author":"A Dunaif","year":"1997","unstructured":"Dunaif A (1997) Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Endocr Rev 18:774\u2013800","journal-title":"Endocr Rev"},{"key":"3433_CR3","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/nrendo.2010.217","volume":"7","author":"MO Goodarzi","year":"2011","unstructured":"Goodarzi MO, Dumesic DA, Chazenbalk G, Azziz R (2011) Polycystic ovary syndrome: etiology, pathogenesis and diagnosis. Nat Rev Endocrinol 7:219\u2013231","journal-title":"Nat Rev Endocrinol"},{"key":"3433_CR4","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/humrep\/deh098","volume":"19","author":"Rotterdam ESHRE\/ASRM-Sponsored PCOS Consensus Workshop Group","year":"2003","unstructured":"Rotterdam ESHRE\/ASRM-Sponsored PCOS Consensus Workshop Group (2003) Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 19:41\u201347","journal-title":"Hum Reprod"},{"key":"3433_CR5","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1056\/NEJMra041536","volume":"352","author":"DA Ehrmann","year":"2005","unstructured":"Ehrmann DA (2005) Polycystic ovary syndrome. N Engl J Med 352:1223\u20131236","journal-title":"N Engl J Med"},{"key":"3433_CR6","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0889-8529(05)70069-4","volume":"28","author":"CG Solomon","year":"1999","unstructured":"Solomon CG (1999) The epidemiology of polycystic ovary syndrome. Prevalence and associated disease risks. Endocrinol Metab Clin North Am 28:247\u2013263","journal-title":"Endocrinol Metab Clin North Am"},{"key":"3433_CR7","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1210\/jcem-65-3-499","volume":"65","author":"A Dunaif","year":"1987","unstructured":"Dunaif A, Graf M, Mandeli J, Laumas V, Dobrjansky A (1987) Characterization of groups of hyperandrogenic women with acanthosis nigricans, impaired glucose tolerance, and\/or hyperinsulinemia. J Clin Endocrinol Metab 65:499\u2013507","journal-title":"J Clin Endocrinol Metab"},{"key":"3433_CR8","first-page":"556","volume":"82","author":"DJ Jakubowicz","year":"1997","unstructured":"Jakubowicz DJ, Nestler JE (1997) 17 alpha-hydroxyprogesterone responses to leuprolide and serum androgens in obese women with and without polycystic ovary syndrome offer dietary weight loss. J Clin Endocrinol Metab 82:556\u2013560","journal-title":"J Clin Endocrinol Metab"},{"key":"3433_CR9","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1210\/jcem-67-3-460","volume":"67","author":"SR Plymate","year":"1998","unstructured":"Plymate SR, Matej LA, Jones RE, Friedl KE (1998) Inhibition of sex hormone-binding globulin production in the human hepatoma (Hep G2) cell line by insulin and prolactin. J Clin Endocrinol Metab 67:460\u2013464","journal-title":"J Clin Endocrinol Metab"},{"key":"3433_CR10","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1210\/jcem-72-1-83","volume":"72","author":"JE Nestler","year":"1991","unstructured":"Nestler JE, Powers LP, Matt DW et al (1991) A direct effect of hyperinsulinemia on serum sex hormone-binding globulin levels in obese women with the polycystic ovary syndrome. J Clin Endocrinol Metab 72:83\u201389","journal-title":"J Clin Endocrinol Metab"},{"key":"3433_CR11","first-page":"77","volume":"38","author":"T Utsunomiya","year":"1993","unstructured":"Utsunomiya T, Taniguchi I, Sadanaga A, Iwasato K, Mizoguchi Y, Terawaki S (1993) Insulin resistance in non-obese patients with polycystic ovary syndrome. Jpn J Fertil Steril 38:77\u201381","journal-title":"Jpn J Fertil Steril"},{"key":"3433_CR12","first-page":"1686","volume":"79","author":"RL Rosenfield","year":"1994","unstructured":"Rosenfield RL, Barnes RB, Ehrmann DA (1994) Studies of the nature of 17-hydroxyprogesterone hyperresponsiveness to gonadotropin-releasing hormone agonist challenge in functional ovarian hyperandrogenism. J Clin Endocrinol Metab 79:1686\u20131692","journal-title":"J Clin Endocrinol Metab"},{"key":"3433_CR13","first-page":"3","volume":"2001","author":"M Egger","year":"2001","unstructured":"Egger M, Smith GD, Altman DG (2001) Systematic reviews in health care: meta-analysis in context. BMJ 2001:3\u201368","journal-title":"BMJ"},{"key":"3433_CR14","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1210\/jc.2007-1834","volume":"93","author":"BO Yildiz","year":"2008","unstructured":"Yildiz BO, Knochenhauer ES, Azziz R (2008) Impact of obesity on the risk for polycystic ovary syndrome. J Clin Endocrinol Metab 93:162\u2013168","journal-title":"J Clin Endocrinol Metab"},{"key":"3433_CR15","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1210\/jc.2004-1045","volume":"90","author":"T Apridonidze","year":"2005","unstructured":"Apridonidze T, Essah PA, Iuorno MJ, Nestler JE (2005) Prevalence and characteristics of the metabolic syndrome in women with polycystic ovary syndrome. J Clin Endocrinol Metab 90:1929\u20131935","journal-title":"J Clin Endocrinol Metab"},{"key":"3433_CR16","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.2337\/diacare.24.6.1050","volume":"24","author":"HR Peppard","year":"2001","unstructured":"Peppard HR, Marfori J, Iuorno MJ, Nestler JE (2001) Prevalence of polycystic ovary syndrome among premenopausal women with type 2 diabetes. Diabetes Care 24:1050\u20131052","journal-title":"Diabetes Care"},{"key":"3433_CR17","first-page":"25","volume":"14","author":"SS Lim","year":"2013","unstructured":"Lim SS, Norman RJ, Davies MJ, Moran LJ (2013) The effect of obesity on polycystic ovary syndrome: a systematic review and meta-analysis. Obes Rev 14:25\u2013109","journal-title":"Obes Rev"},{"key":"3433_CR18","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1038\/sj.ijo.0801994","volume":"26","author":"A Gambineri","year":"2002","unstructured":"Gambineri A, Pelusi C, Vicennati V, Pagotto U, Pasquali R (2002) Obesity and the polycystic ovary syndrome. Int J Obes Metab Disord 26:883\u2013896","journal-title":"Int J Obes Metab Disord"},{"key":"3433_CR19","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1016\/j.fertnstert.2004.11.070","volume":"83","author":"CM DeUgarte","year":"2005","unstructured":"DeUgarte CM, Bartolucci AA, Azziz R (2005) Prevalence of insulin resistance in the polycystic ovary syndrome using the homeostasis model assessment. Fertil Steril 83:1454\u20131460","journal-title":"Fertil Steril"},{"key":"3433_CR20","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.fertnstert.2004.01.041","volume":"82","author":"E Carmina","year":"2004","unstructured":"Carmina E, Lobo RA (2004) Use of fasting blood to assess the prevalence of insulin resistance in women with polycystic ovary syndrome. Fertil Steril 82:661\u2013665","journal-title":"Fertil Steril"},{"key":"3433_CR21","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.fertnstert.2008.06.035","volume":"91","author":"R Azziz","year":"2009","unstructured":"Azziz R, Carmina E, Dewailly D et al (2009) The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report. Fertil Steril 91:456\u2013488","journal-title":"Fertil Steril"},{"key":"3433_CR22","doi-asserted-by":"crossref","first-page":"2500","DOI":"10.1210\/jc.2006-2725","volume":"92","author":"E Carmina","year":"2007","unstructured":"Carmina E, Bucchieri S, Esposito A (2007) Abdominal fat quantity and distribution in women with polycystic ovary syndrome and extent of its relation to insulin resistance. J Clin Endocrinol Metab 92:2500\u20132505","journal-title":"J Clin Endocrinol Metab"},{"key":"3433_CR23","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1385\/ENDO:30:1:13","volume":"30","author":"E Diamanti-Kandarakis","year":"2006","unstructured":"Diamanti-Kandarakis E (2006) Insulin resistance in PCOS. Endocrine 30:13\u201317","journal-title":"Endocrine"},{"key":"3433_CR24","first-page":"6","volume":"7","author":"F Geisth\u00f6vel","year":"2010","unstructured":"Geisth\u00f6vel F (2010) Novel systematics of nomenclature and classification of female functional androgenization (including polycystic ovary syndrome and non-classic congenital adrenal hyperplasia). J Reprod Med Endokrinol 7:6\u201326","journal-title":"J Reprod Med Endokrinol"},{"key":"3433_CR25","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1093\/humrep\/den433","volume":"24","author":"AJ Goverde","year":"2009","unstructured":"Goverde AJ, van Koert AJ, Eijkemans MJ, Knauff EA, Westerveld HE, Fauser BC, Broekmans FJ (2009) Indicators for metabolic disturbances in anovulatory women with polycystic ovary syndrome diagnosed according to the Rotterdam consensus criteria. Hum Reprod 24:710","journal-title":"Hum Reprod"},{"key":"3433_CR26","first-page":"CD003053","volume":"3","author":"JM Lord","year":"2003","unstructured":"Lord JM, Flight IH, Norman RJ (2003) Insulin sensitising drugs (metformin, troglitazone, rosiglitazone, pioglitazone, D-chiro-inositol) for polycystic ovary syndrome. Cochrane Database Syst Rev 3:CD003053","journal-title":"Cochrane Database Syst Rev"},{"issue":"7","key":"3433_CR27","doi-asserted-by":"crossref","first-page":"4068","DOI":"10.1210\/jc.2005-0110","volume":"90","author":"S Palomba","year":"2005","unstructured":"Palomba S, Orio F Jr, Falbo A, Manguso F, Russo T, Cascella T, Tolino A, Carmina E, Colao A, Zullo F (2005) Prospective parallel randomized, double-blind, double-dummy controlled clinical trial comparing clomiphene citrate and metformin as the first-line treatment for ovulation induction in nonobese anovulatory women with polycystic ovary syndrome. J Clin Endocrinol Metab 90(7):4068\u20134074","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"3433_CR28","doi-asserted-by":"crossref","first-page":"4801","DOI":"10.1210\/jc.2004-0689","volume":"89","author":"S Palomba","year":"2004","unstructured":"Palomba S, Orio F Jr, Nardo LG, Falbo A, Russo T, Corea D, Doldo P, Lombardi G, Tolino A, Colao A, Zullo F (2004) Metformin administration versus laparoscopic ovarian diathermy in clomiphene citrate-resistant women with polycystic ovary syndrome: a prospective parallel randomized double-blind placebo-controlled trial. J Clin Endocrinol Metab 89(10):4801\u20134809","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"3433_CR29","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.fertnstert.2003.08.012","volume":"81","author":"GA Maciel","year":"2004","unstructured":"Maciel GA, Soares J\u00fanior JM, Alves da Motta EL, Abi Haidar M, de Lima GR, Baracat EC (2004) Nonobese women with polycystic ovary syndrome respond better than obese women to treatment with metformin. Fertil Steril 81(2):355\u2013360","journal-title":"Fertil Steril"},{"issue":"1","key":"3433_CR30","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/S1472-6483(10)60809-7","volume":"10","author":"AS Kumari","year":"2005","unstructured":"Kumari AS, Haq A, Jayasundaram R, Abdel-Wareth LO, Al Haija SA, Alvares M (2005) Metformin monotherapy in lean women with polycystic ovary syndrome. Reprod Biomed Online 10(1):100\u2013104","journal-title":"Reprod Biomed Online"},{"issue":"5","key":"3433_CR31","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1530\/EJE-07-0294","volume":"157","author":"S Tan","year":"2007","unstructured":"Tan S, Hahn S, Benson S, Dietz T, Lahner H, Moeller LC, Schmidt M, Elsenbruch S, Kimmig R, Mann K, Janssen OE (2007) Metformin improves polycystic ovary syndrome symptoms irrespective of pre-treatment insulin resistance. Eur J Endocrinol 157(5):669\u2013676","journal-title":"Eur J Endocrinol"},{"key":"3433_CR32","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.fertnstert.2011.09.024","volume":"97","author":"BC Fauser","year":"2012","unstructured":"Fauser BC, Tarlatzis BC, Rebar RW, Legro RS, Balen AH, Lobo R, Carmina E, Chang J, Yildiz BO, Laven JS, Boivin J, Petraglia F, Wijeyeratne CN, Norman RJ, Dunaif A, Franks S, Wild RA, Dumesic D, Barnhart K (2012) Consensus on women\u2019s health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE\/ASRM-Sponsored 3rd PCOS Consensus Workshop Group. Fertil Steril 97:28\u201338","journal-title":"Fertil Steril"},{"issue":"2","key":"3433_CR33","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1530\/EJE-12-0655","volume":"168","author":"D Panidis","year":"2013","unstructured":"Panidis D, Tziomalos K, Chatzis P, Papadakis E, Delkos D, Tsourdi EA, Kandaraki EA, Katsikis I (2013) Association between menstrual cycle irregularities and endocrine and metabolic characteristics of the polycystic ovary syndrome. Eur J Endocrinol 168(2):145\u2013152","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"3433_CR34","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/j.1365-2265.1993.tb02376.x","volume":"39","author":"S Robinson","year":"1993","unstructured":"Robinson S, Kiddy D, Gelding SV, Willis D, Niththyananthan R, Bush A, Johnston DG, Franks S (1993) The relationship of insulin insensitivity to menstrual pattern in women with hyperandrogenism and polycystic ovaries. Clin Endocrinol (Oxf) 39(3):351\u2013355","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"6","key":"3433_CR35","first-page":"2428","volume":"86","author":"S Gill","year":"2001","unstructured":"Gill S, Taylor AE, Martin KA, Welt CK, Adams JM, Hall JE (2001) Specific factors predict the response to pulsatile gonadotropin-releasing hormone therapy in polycystic ovarian syndrome. J Clin Endocrinol Metab 86(6):2428\u20132436","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"3433_CR36","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1530\/EJE-07-0515","volume":"158","author":"S Cupisti","year":"2008","unstructured":"Cupisti S, Kajaia N, Dittrich R, Duezenli H, Beckmann M W, Mueller A (2008) Body mass index and ovarian function are associated with endocrine and metabolic abnormalities in women with hyperandrogenic syndrome. Eur J Endocrinol 158(5):711\u2013719. doi: 10.1530\/EJE-07-0515","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"3433_CR37","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.ejogrb.2009.12.024","volume":"149","author":"T Strowitzki","year":"2010","unstructured":"Strowitzki T, Capp E, von Eye Corleta H (2010) The degree of cycle irregularity correlates with the grade of endocrine and metabolic disorders in PCOS patients. Eur J Obstet Gynecol Reprod Biol 149(2):178\u2013181. doi: 10.1016\/j.ejogrb.2009.12.024","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"12","key":"3433_CR38","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.1093\/humrep\/16.12.2606","volume":"16","author":"JX Wang","year":"2001","unstructured":"Wang JX, Davies MJ, Norman RJ (2001) Polycystic ovarian syndrome and the risk of spontaneous abortion following assisted reproductive technology treatment. Hum Reprod 16(12):2606\u20132609","journal-title":"Hum Reprod"},{"issue":"1","key":"3433_CR39","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1055\/s-2007-992927","volume":"26","author":"CM Boomsma","year":"2008","unstructured":"Boomsma CM, Fauser BC, Macklon NS (2008) Pregnancy complications in women with polycystic ovary syndrome. Semin Reprod Med 26(1):72\u201384. doi: 10.1055\/s-2007-992927","journal-title":"Semin Reprod Med"},{"issue":"6","key":"3433_CR40","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1095\/biolreprod59.6.1445","volume":"59","author":"JJ Eppig","year":"1998","unstructured":"Eppig JJ, O\u2019Brien MJ, Pendola FL, Watanabe S (1998) Factors affecting the developmental competence of mouse oocytes grown in vitro: follicle-stimulating hormone and insulin. Biol Reprod 59(6):1445\u20131453","journal-title":"Biol Reprod"},{"key":"3433_CR41","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1586\/17446651.4.2.183","volume":"4","author":"A Galal","year":"2009","unstructured":"Galal A, Mitwally MF (2009) Insulin sensitizers for women with polycystic ovarian syndrome. Expert Rev Endocrinol Metab 4:183\u2013192","journal-title":"Expert Rev Endocrinol Metab"},{"issue":"3","key":"3433_CR42","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1210\/jcem.87.3.8287","volume":"87","author":"DA Dumesic","year":"2002","unstructured":"Dumesic DA, Schramm RD, Peterson E, Paprocki AM, Zhou R, Abbott DH (2002) Impaired developmental competence of oocytes in adult prenatally androgenized female rhesus monkeys undergoing gonadotropin stimulation for in vitro fertilization. J Clin Endocrinol Metab 87(3):1111\u20131119","journal-title":"J Clin Endocrinol Metab"},{"key":"3433_CR43","doi-asserted-by":"crossref","unstructured":"Tao Z, Yan L (2005) Luteinizing hormone and insulin inducing earlier and excess expression of luteinizing hormone receptor messenger ribonucleic acids in granulosa cells of polycystic ovary syndrome. Fertil Steril 84(Suppl):S426\u2013S427","DOI":"10.1016\/j.fertnstert.2005.07.1115"},{"key":"3433_CR44","doi-asserted-by":"crossref","first-page":"e3","DOI":"10.1017\/S1462399408000598","volume":"10","author":"E Diamanti-Kandarakis","year":"2008","unstructured":"Diamanti-Kandarakis E (2008) Polycystic ovarian syndrome: pathophysiology, molecular aspects and clinical implications. Expert Rev Mol Med 10:e3","journal-title":"Expert Rev Mol Med"},{"issue":"3","key":"3433_CR45","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1055\/s-2003-43310","volume":"21","author":"S Jabara","year":"2003","unstructured":"Jabara S, Coutifaris C (2003) In vitro fertilization in the PCOS patient: clinical considerations. Semin Reprod Med 21(3):317\u2013324","journal-title":"Semin Reprod Med"},{"issue":"5","key":"3433_CR46","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1007\/BF02765826","volume":"14","author":"F Cano","year":"1997","unstructured":"Cano F, Garc\u00eda-Velasco JA, Millet A, Remoh\u00ed J, Sim\u00f3n C, Pellicer A (1997) Oocyte quality in polycystic ovaries revisited: identification of a particular subgroup of women. J Assist Reprod Genet 14(5):254\u2013261","journal-title":"J Assist Reprod Genet"},{"issue":"1\u20132","key":"3433_CR47","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0303-7207(02)00114-4","volume":"192","author":"PR Kezele","year":"2002","unstructured":"Kezele PR, Nilsson EE, Skinner MK (2002) Insulin but not insulin-like growth factor-1 promotes the primordial to primary follicle transition. Mol Cell Endocrinol 192(1\u20132):37\u201343","journal-title":"Mol Cell Endocrinol"},{"key":"3433_CR48","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1210\/jc.2006-2123","volume":"92","author":"JR Wood","year":"2007","unstructured":"Wood JR, Dumesic DA, Abbott DH, Strauss JF (2007) Molecular abnormalities in oocytes from women with polycystic ovary syndrome revealed by microarray analysis. J Clin Endocrinol Metab 92:705\u2013713. doi: 10.1210\/jc.2006-2123","journal-title":"J Clin Endocrinol Metab"},{"key":"3433_CR49","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1210\/jc.2005-2327","volume":"91","author":"F Gonz\u00e1lez","year":"2006","unstructured":"Gonz\u00e1lez F, Rote NS, Minium J, Kirwan JP (2006) Increased activation of nuclear factor kB triggers inflammation and insulin resistance in polycystic ovary syndrome. J Clin Endocrinol Metab 91:1508\u20131512","journal-title":"J Clin Endocrinol Metab"},{"issue":"2 Suppl","key":"3433_CR50","first-page":"319A","volume":"12","author":"PC Piotrowski","year":"2005","unstructured":"Piotrowski PC, Rzepczynska IJ, Kwintkiewicz J, Duleba AJ (2005) Oxidative stress induces expression of CYP11A, CYP17, STAR and 3bHSD in rat theca-interstitial cells. J Soc Gynecol Invest 12(2 Suppl):319A","journal-title":"J Soc Gynecol Invest"},{"key":"3433_CR51","doi-asserted-by":"crossref","first-page":"5336","DOI":"10.1210\/jc.2005-0694","volume":"90","author":"F Gonz\u00e1lez","year":"2005","unstructured":"Gonz\u00e1lez F, Minium J, Rote NS, Kirwan JP (2005) Hyperglycemia alters tumor necrosis factor-a release from mononuclear cells in women with polycystic ovary syndrome. J Clin Endocrinol Metab 90:5336\u20135342","journal-title":"J Clin Endocrinol Metab"},{"key":"3433_CR52","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1677\/joe.1.06579","volume":"188","author":"F Gonz\u00e1lez","year":"2006","unstructured":"Gonz\u00e1lez F, Rote NS, Minium J, Kirwan JP (2006) In vitro evidence that hyperglycemia stimulates tumor necrosis factor-a release in obese women with polycystic ovary syndrome. J Endocrinol 188:521\u2013529","journal-title":"J Endocrinol"},{"key":"3433_CR53","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1210\/jc.2005-1696","volume":"91","author":"F Gonz\u00e1lez","year":"2006","unstructured":"Gonz\u00e1lez F, Rote NS, Minium J, Kirwan JP (2006) Reactive oxygen species-induced oxidative stress in the development of insulin resistance and hyperandrogenism in polycystic ovary syndrome. J Clin Endocrinol Metab 91:336\u2013340","journal-title":"J Clin Endocrinol Metab"},{"key":"3433_CR54","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1016\/j.metabol.2009.02.022","volume":"58","author":"F Gonz\u00e1lez","year":"2009","unstructured":"Gonz\u00e1lez F, Rote NS, Minium J, Kirwan JP (2009) Evidence of proatherogenic inflammation in polycystic ovary syndrome. Metabolism 58:954\u2013962","journal-title":"Metabolism"},{"key":"3433_CR55","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1210\/jc.2009-1158","volume":"95","author":"G Chazenbalk","year":"2010","unstructured":"Chazenbalk G, Trivax BS, Yildiz BO (2010) Regulation of adiponectin secretion by adipocytes in the polycystic ovary syndrome: role of tumor necrosis factor-{alpha}. J Clin Endocrinol Metab 95:935\u2013942","journal-title":"J Clin Endocrinol Metab"},{"key":"3433_CR56","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1530\/eje.1.01868","volume":"152","author":"E Carmina","year":"2005","unstructured":"Carmina E, Orio F, Palomba S (2005) Evidence for altered adipocyte function in polycystic ovary syndrome. Eur J Endocrinol 152:389\u2013394","journal-title":"Eur J Endocrinol"},{"key":"3433_CR57","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1530\/JME-12-0247","volume":"50","author":"X Chen","year":"2013","unstructured":"Chen X, Jia X, Qiao J, Guan Y, Kang J (2013) Adipokines in reproductive function: a link between obesity and polycystic ovary syndrome. J Mol Endocrinol 50:21\u201337","journal-title":"J Mol Endocrinol"},{"key":"3433_CR58","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1159\/000341840","volume":"40","author":"E Carmina","year":"2013","unstructured":"Carmina E (2013) Obesity, adipokines and metabolic syndrome in polycystic ovary syndrome. Front Horm Res 40:40\u201350","journal-title":"Front Horm Res"},{"key":"3433_CR59","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1016\/j.fertnstert.2008.09.008","volume":"92","author":"C Chabrolle","year":"2009","unstructured":"Chabrolle C, Tosca L, Ram\u00e9 C, Lecomte P, Roy\u00e8re D, Dupont J (2009) Adiponectin increases insulin-like growth factor l-induced progesterone and estradiol secretion in human granulosa cells. Fertil Steril 92:1988\u20131996","journal-title":"Fertil Steril"},{"key":"3433_CR60","doi-asserted-by":"crossref","first-page":"874","DOI":"10.3109\/09513590.2010.487586","volume":"26","author":"M Pusalkar","year":"2010","unstructured":"Pusalkar M, Meherji P, Gokral J, Savardekar L, Chinnaraj S, Maitra A (2010) Obesity and polycystic ovary syndrome: association with androgens, leptin and its genotypes. Gynecol Endocrinol 26:874\u2013882","journal-title":"Gynecol Endocrinol"},{"issue":"8","key":"3433_CR61","doi-asserted-by":"crossref","first-page":"e80416","DOI":"10.1371\/journal.pone.0080416","volume":"18","author":"FV Comim","year":"2013","unstructured":"Comim FV, Hardy K, Franks S (2013) Adiponectin and its receptors in the ovary: further evidence for a link between obesity and hyperandrogenism in polycystic ovary syndrome. PLoS ONE 18(8):e80416","journal-title":"PLoS ONE"},{"key":"3433_CR62","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1093\/humrep\/deg353","volume":"18","author":"D Panidis","year":"2003","unstructured":"Panidis D, Kourtis A, Farmakiotis D, Mouslech T, Rousso D, Koliakos G (2003) Serum adiponectin levels in women with polycystic ovary syndrome. Hum Reprod 18:1790\u20131796","journal-title":"Hum Reprod"},{"key":"3433_CR63","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1016\/j.fertnstert.2004.11.077","volume":"83","author":"MS Ardawi","year":"2005","unstructured":"Ardawi MS, Rouzi AA (2005) Plasma adiponectin and insulin resistance in women with polycystic ovary syndrome. Fertil Steril 83:1708\u20131716","journal-title":"Fertil Steril"},{"issue":"9","key":"3433_CR64","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1093\/humrep\/del146","volume":"21","author":"HF Escobar-Morreale","year":"2006","unstructured":"Escobar-Morreale HF, Villuendas G, Botella-Carretero JI, Alvarez-Blasco F, Sanch\u00f3n R, Luque-Ram\u00edrez M, San Mill\u00e1n JL (2006) Adiponectin and resistin in PCOS: a clinical, biochemical and molecular genetic study. Hum Reprod 21(9):2257\u20132265","journal-title":"Hum Reprod"},{"issue":"6","key":"3433_CR65","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1111\/j.1365-2265.2009.03604.x","volume":"71","author":"O Pinhas-Hamiel","year":"2009","unstructured":"Pinhas-Hamiel O, Singer S, Pilpel N, Koren I, Boyko V, Hemi R, Pariente C, Kanety H (2009) Adiponectin levels in adolescent girls with polycystic ovary syndrome (PCOS). Clin Endocrinol (Oxf) 71(6):823\u2013827. doi: 10.1111\/j.1365-2265.2009.03604.x","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"2","key":"3433_CR66","doi-asserted-by":"crossref","first-page":"E304","DOI":"10.1210\/jc.2010-1290","volume":"96","author":"L Manner\u00e5s-Holm","year":"2011","unstructured":"Manner\u00e5s-Holm L, Leonhardt H, Kullberg J, Jennische E, Od\u00e9n A, Holm G et al (2011) Adipose tissue has aberrant morphology and function in PCOS: enlarged adipocytes and low serum adiponectin, but not circulating sex steroids, are strongly associated with insulin resistance. J Clin Endocrinol Metab 96(2):E304\u2013E311. doi: 10.1210\/jc.2010-1290","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"3433_CR67","doi-asserted-by":"crossref","first-page":"243","DOI":"10.4082\/kjfm.2011.32.4.243","volume":"32","author":"HY Shin","year":"2011","unstructured":"Shin HY, Lee DC, Lee JW (2011) Adiponectin in women with polycystic ovary syndrome. Korean J Fam Med 32(4):243\u2013248. doi: 10.4082\/kjfm.2011.32.4.243","journal-title":"Korean J Fam Med"},{"issue":"6","key":"3433_CR68","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1016\/j.fertnstert.2011.02.041","volume":"95","author":"SB Lecke","year":"2011","unstructured":"Lecke SB, Mattei F, Morsch DM, Spritzer PM (2011) Abdominal subcutaneous fat gene expression and circulating levels of leptin and adiponectin in polycystic ovary syndrome. Fertil Steril 95(6):2044\u20132049. doi: 10.1016\/j.fertnstert.2011.02.041","journal-title":"Fertil Steril"},{"key":"3433_CR69","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1093\/humupd\/dmp006","volume":"15","author":"KA Toulis","year":"2009","unstructured":"Toulis KA, Gouli DG, Farmakiotis D, Georgopoulos NA, Katsikis I, Tarlatzis BC, Papadima I, Panidis D (2009) Adiponectin levels in women with polycystic ovary syndrome: a systematic review and a meta-analysis. Hum Reprod Update 15:297\u2013307. doi: 10.1093\/humupd\/dmp006","journal-title":"Hum Reprod Update"},{"key":"3433_CR70","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1038\/nature01705","volume":"423","author":"T Yamauchi","year":"2003","unstructured":"Yamauchi T, Kamon J, Ito Y et al (2003) Cloning of adiponectin receptors that mediate antidiabetic metabolic effects. Nature 423:762\u2013769","journal-title":"Nature"},{"key":"3433_CR71","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1111\/jog.12101","volume":"39","author":"OH Hossam","year":"2013","unstructured":"Hossam OH (2013) Role of adiponectin and its receptor in prediction of reproductive outcome of metformin treatment in patients with polycystic ovarian syndrome. J Obstet Gynaecol Res 39:1596\u20131603","journal-title":"J Obstet Gynaecol Res"},{"key":"3433_CR72","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/S1357-2725(97)00050-2","volume":"29","author":"RV Considine","year":"1997","unstructured":"Considine RV, Caro JF (1997) Leptin and the regulation of body weight. Int J Biochem Cell Biol 29:1255\u20131272","journal-title":"Int J Biochem Cell Biol"},{"key":"3433_CR73","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1053\/beem.2002.0223","volume":"16","author":"DM Muoio","year":"2002","unstructured":"Muoio DM, Lynis DG (2002) Peripheral metabolic actions of leptin. Best Pract Res Clin Endocrinol Metab 16:653\u2013666","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"3433_CR74","doi-asserted-by":"crossref","unstructured":"Bjorbaek C, Kahn BB (2004) Leptin signaling in the central nervous system and the periphery. Recent Prog Horm Res 59:305\u2013331","DOI":"10.1210\/rp.59.1.305"},{"key":"3433_CR75","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1038\/sj.ijo.0802142","volume":"26","author":"S Margetic","year":"2002","unstructured":"Margetic S, Gazzola C, Pegg GG, Hill RA (2002) Leptin: a review of its peripheral actions and interactions. Int J Obes Relat Metab Disord 26:1407\u20131433","journal-title":"Int J Obes Relat Metab Disord"},{"issue":"11","key":"3433_CR76","first-page":"4166","volume":"81","author":"PR Brzechffa","year":"1996","unstructured":"Brzechffa PR, Jakimiuk AJ, Agarwal SK, Weitsman SR, Buyalos RP, Magoffin DA (1996) Serum immunoreactive leptin concentrations in women with polycystic ovary syndrome. J Clin Endocrinol Metab 81(11):4166\u20134169","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"3433_CR77","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1016\/S0026-0495(98)90356-0","volume":"47","author":"V Vicennati","year":"1998","unstructured":"Vicennati V, Gambineri A, Calzoni F, Casimirri F, Macor C, Vettor R, Pasquali R (1998) Serum leptin in obese women with polycystic ovary syndrome is correlated with body weight and fat distribution but not with androgen and insulin levels. Metabolism 47(8):988\u2013992","journal-title":"Metabolism"},{"issue":"2","key":"3433_CR78","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1080\/13625180802549962","volume":"14","author":"B Pehlivanov","year":"2009","unstructured":"Pehlivanov B, Mitkov M (2009) Serum leptin levels correlate with clinical and biochemical indices of insulin resistance in women with polycystic ovary syndrome. Eur J Contracept Reprod Health Care 14(2):153\u2013159. doi: 10.1080\/13625180802549962","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"3433_CR79","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.fertnstert.2011.04.073","volume":"96","author":"R Yildizhan","year":"2011","unstructured":"Yildizhan R, Ilhan GA, Yildizhan B, Kolusari A, Adali E, Bugdayci G (2011) Serum retinol binding protein 4, leptin, and plasma asymmetric dimethylarginine levels in obese and non-obese young women with polycystic ovary syndrome. Fertil Steril 96:246\u2013250","journal-title":"Fertil Steril"},{"issue":"2","key":"3433_CR80","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1046\/j.1365-2265.1997.1200936.x","volume":"46","author":"IM Chapman","year":"1997","unstructured":"Chapman IM, Wittert GA, Norman RJ (1997) Circulating leptin concentrations in polycystic ovary syndrome: relation to anthropometric and metabolic parameters. Clin Endocrinol (Oxf) 46(2):175\u2013181","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"6","key":"3433_CR81","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1210\/jcem.82.6.3996","volume":"82","author":"J Rouru","year":"1997","unstructured":"Rouru J, Anttila L, Koskinen P, Penttil\u00e4 TA, Irjala K, Huupponen R, Koulu M (1997) Serum leptin concentrations in women with polycystic ovary syndrome. J Clin Endocrinol Metab 82(6):1697\u20131700","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"3433_CR82","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1093\/humrep\/13.3.535","volume":"13","author":"G Gennarelli","year":"1998","unstructured":"Gennarelli G, Holte J, Wide L, Berne C, Lithell H (1998) Is there a role for leptin in the endocrine and metabolic aberrations of polycystic ovary syndrome? Hum Reprod 13(3):535\u2013541","journal-title":"Hum Reprod"},{"issue":"4 Suppl","key":"3433_CR83","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1016\/j.fertnstert.2008.03.007","volume":"1","author":"E Carmina","year":"2009","unstructured":"Carmina E, Bucchieri S, Mansueto P, Rini G, Ferin M, Lobo RA (2009) Circulating levels of adipose products and differences in fat distribution in the ovulatory and anovulatory phenotypes of polycystic ovary syndrome. Fertil Steril 1(4 Suppl):1332\u20131335. doi: 10.1016\/j.fertnstert.2008.03.007","journal-title":"Fertil Steril"},{"key":"3433_CR84","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1017\/S0007114511002583","volume":"107","author":"P Wang","year":"2012","unstructured":"Wang P, Holst C, Astrup A et al (2012) Blood profiling of proteins and steroids during weight maintenance with manipulation of dietary protein level and glycaemic index. Br J Nutr 107:106\u2013119","journal-title":"Br J Nutr"},{"issue":"1","key":"3433_CR85","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.fertnstert.2012.03.056","volume":"98","author":"PF Svendsen","year":"2012","unstructured":"Svendsen PF, Christiansen M, Hedley PL, Nilas L, Pedersen SB, Madsbad S (2012) Adipose expression of adipocytokines in women with polycystic ovary syndrome. Fertil Steril 98(1):235\u2013241. doi: 10.1016\/j.fertnstert.2012.03.056","journal-title":"Fertil Steril"},{"key":"3433_CR86","doi-asserted-by":"crossref","first-page":"25","DOI":"10.4149\/endo_2010_01_25","volume":"44","author":"A Stofkova","year":"2010","unstructured":"Stofkova A (2010) Resistin and visfatin: regulators of insulin sensitivity, inflammation and immunity. Endocr Regul 44:25\u201336","journal-title":"Endocr Regul"},{"issue":"12","key":"3433_CR87","doi-asserted-by":"crossref","first-page":"5022","DOI":"10.1210\/jc.2006-0936","volume":"91","author":"BK Tan","year":"2006","unstructured":"Tan BK, Chen J, Digby JE, Keay SD, Kennedy CR, Randeva HS (2006) Increased visfatin messenger ribonucleic acid and protein levels in adipose tissue and adipocytes in women with polycystic ovary syndrome: parallel increase in plasma visfatin. J Clin Endocrinol Metab 91(12):5022\u20135028","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"3433_CR88","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.fertnstert.2006.11.120","volume":"88","author":"TF Chan","year":"2007","unstructured":"Chan TF, Chen YL, Chen HH, Lee CH, Jong SB, Tsai EM (2007) Increased plasma visfatin concentrations in women with polycystic ovary syndrome. Fertil Steril 88(2):401\u2013405","journal-title":"Fertil Steril"},{"issue":"7","key":"3433_CR89","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1093\/humrep\/dem118","volume":"22","author":"I Kowalska","year":"2007","unstructured":"Kowalska I, Straczkowski M, Nikolajuk A, Adamska A, Karczewska-Kupczewska M, Otziomek E, Wolczynski S, Gorska M (2007) Serum visfatin in relation to insulin resistance and markers of hyperandrogenism in lean and obese women with polycystic ovary syndrome. Hum Reprod 22(7):1824\u20131829","journal-title":"Hum Reprod"},{"issue":"6","key":"3433_CR90","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.ejim.2007.05.014","volume":"19","author":"D Panidis","year":"2008","unstructured":"Panidis D, Farmakiotis D, Rousso D, Katsikis I, Delkos D, Piouka A, Gerou S, Diamanti-Kandarakis E (2008) Plasma visfatin levels in normal weight women with polycystic ovary syndrome. Eur J Intern Med 19(6):406\u2013412. doi: 10.1016\/j.ejim.2007.05.014","journal-title":"Eur J Intern Med"},{"issue":"3","key":"3433_CR91","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/j.fertnstert.2008.10.058","volume":"93","author":"M Ozkaya","year":"2010","unstructured":"Ozkaya M, Cakal E, Ustun Y, Engin-Ustun Y (2010) Effect of metformin on serum visfatin levels in patients with polycystic ovary syndrome. Fertil Steril 93(3):880\u2013884. doi: 10.1016\/j.fertnstert.2008.10.058","journal-title":"Fertil Steril"},{"issue":"4","key":"3433_CR92","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1016\/j.fertnstert.2009.04.055","volume":"94","author":"E Plati","year":"2010","unstructured":"Plati E, Kouskouni E, Malamitsi-Puchner A, Boutsikou M, Kaparos G, Baka S (2010) Visfatin and leptin levels in women with polycystic ovaries undergoing ovarian stimulation. Fertil Steril 94(4):1451\u20131456. doi: 10.1016\/j.fertnstert.2009.04.055","journal-title":"Fertil Steril"},{"issue":"10","key":"3433_CR93","doi-asserted-by":"crossref","first-page":"2869","DOI":"10.1093\/humrep\/der267","volume":"26","author":"KM Seow","year":"2011","unstructured":"Seow KM, Hwang JL, Wang PH, Ho LT, Juan CC (2011) Expression of visfatin mRNA in peripheral blood mononuclear cells is not correlated with visfatin mRNA in omental adipose tissue in women with polycystic ovary syndrome. Hum Reprod 26(10):2869\u20132873. doi: 10.1093\/humrep\/der267","journal-title":"Hum Reprod"},{"issue":"4","key":"3433_CR94","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1159\/000341579","volume":"5","author":"N Spanos","year":"2012","unstructured":"Spanos N, Tziomalos K, Macut D, Koiou E, Kandaraki EA, Delkos D, Tsourdi E, Panidis D (2012) Adipokines, insulin resistance and hyperandrogenemia in obese patients with polycystic ovary syndrome: cross-sectional correlations and the effects of weight loss. Obes Facts 5(4):495\u2013504. doi: 10.1159\/000341579","journal-title":"Obes Facts"},{"issue":"8","key":"3433_CR95","doi-asserted-by":"crossref","first-page":"619","DOI":"10.3109\/09513590.2011.650749","volume":"28","author":"N G\u00fcd\u00fcc\u00fc","year":"2012","unstructured":"G\u00fcd\u00fcc\u00fc N, \u0130\u015f\u00e7i H, G\u00f6rm\u00fc\u015f U, Yi\u011fiter AB, D\u00fcnder I (2012) Serum visfatin levels in women with polycystic ovary syndrome. Gynecol Endocrinol 28(8):619\u2013623. doi: 10.3109\/09513590.2011.650749","journal-title":"Gynecol Endocrinol"},{"issue":"3","key":"3433_CR96","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1111\/j.1365-2362.2011.02586.x","volume":"42","author":"TK Lajunen","year":"2012","unstructured":"Lajunen TK, Purhonen AK, Haapea M, Ruokonen A, Puukka K, Hartikainen AL et al (2012) Full-length visfatin levels are associated with inflammation in women with polycystic ovary syndrome. Eur J Clin Invest 42(3):321\u2013328. doi: 10.1111\/j.1365-2362.2011.02586.x","journal-title":"Eur J Clin Invest"},{"issue":"1","key":"3433_CR97","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.ejogrb.2012.01.026","volume":"162","author":"M Olszanecka-Glinianowicz","year":"2012","unstructured":"Olszanecka-Glinianowicz M, Madej P, Zdun D, Bo\u017centowicz-Wikarek M, Sikora J, Chudek J, Ska\u0142ba P (2012) Are plasma levels of visfatin and retinol-binding protein 4 (RBP4) associated with body mass, metabolic and hormonal disturbances in women with polycystic ovary syndrome? Eur J Obstet Gynecol Reprod Biol 162(1):55\u201361. doi: 10.1016\/j.ejogrb.2012.01.026","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"3433_CR98","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.fertnstert.2008.05.065","volume":"92","author":"SE Kasim-Karakas","year":"2009","unstructured":"Kasim-Karakas SE, Almario RU, Cunningham W (2009) Effects of protein versus simple sugar intake on weight loss in polycystic ovary syndrome (according to the National Institutes of Health criteria). Fertil Steril 92:262\u2013270","journal-title":"Fertil Steril"},{"key":"3433_CR99","doi-asserted-by":"crossref","first-page":"2944","DOI":"10.1210\/jc.2006-2336","volume":"92","author":"LJ Moran","year":"2007","unstructured":"Moran LJ, Noakes M, Clifton PM, Wittert GA, Belobrajdic DP, Norman RJ (2007) C-reactive protein before and after weight loss in overweight women with and without polycystic ovary syndrome. J Clin Endocrinol Metab 92:2944\u20132951","journal-title":"J Clin Endocrinol Metab"},{"key":"3433_CR100","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.fertnstert.2003.08.023","volume":"81","author":"K Stamets","year":"2004","unstructured":"Stamets K, Taylor DS, Kunselman A, Demers LM, Pelkman CL, Legro RS (2004) A randomized trial of the effects of two types of short-term hypocaloric diets on weight loss in women with polycystic ovary syndrome. Fertil Steril 81:630\u2013637","journal-title":"Fertil Steril"},{"key":"3433_CR101","doi-asserted-by":"crossref","first-page":"E865","DOI":"10.1152\/ajpendo.00458.2001","volume":"282","author":"EW Dam Van","year":"2002","unstructured":"Van Dam EW, Roelfsema F, Veldhuis JD, Helmerhorst FM, Frolich M, Meinders AE, Krans HM, Pijl H (2002) Increase in daily LH secretion in response to short-term calorie restriction in obese women with PCOS. Am J Physiol Endocrinol Metab 282:E865\u2013E872","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"3433_CR102","first-page":"1692","volume":"82","author":"GA Laughlin","year":"1997","unstructured":"Laughlin GA, Morales AJ, Yen SS (1997) Serum leptin levels in women with polycystic ovary syndrome: the role of insulin resistance\/hyperinsulinemia. J Clin Endocrinol Metab 82:1692\u20131696","journal-title":"J Clin Endocrinol Metab"},{"key":"3433_CR103","first-page":"1687","volume":"82","author":"CS Mantzoros","year":"1997","unstructured":"Mantzoros CS, Dunaif A, Flier JS (1997) Leptin concentrations in the polycystic ovary syndrome. J Clin Endocrinol Metab 82:1687\u20131691","journal-title":"J Clin Endocrinol Metab"},{"key":"3433_CR104","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/S0015-0282(98)00053-3","volume":"69","author":"O Muneyvirci-Delale","year":"1998","unstructured":"Muneyvirci-Delale O, Nacharaju VL, Altura BM, Altura BT (1998) Sex steroid hormones modulate serum ionized magnesium and Ca levels throughout the menstrual cycle in women. Fertil Steril 69:958\u2013962","journal-title":"Fertil Steril"},{"key":"3433_CR105","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1080\/07315724.2006.10719563","volume":"25","author":"ME Rumawas","year":"2006","unstructured":"Rumawas ME, McKeown NM, Rogers G, Meigs JB, Wilson PWF, Jacques PF (2006) Magnesium intake is related to improved insulin homeostasis in the Framingham offspring cohort. J Am Coll Nutr 25:486\u2013492","journal-title":"J Am Coll Nutr"},{"key":"3433_CR106","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s12011-012-9592-5","volume":"152","author":"P Chakraborty","year":"2013","unstructured":"Chakraborty P, Ghosh S, Goswami SK, Syed NK, Baidyanath C, Kuladip J (2013) Altered trace mineral milieu might play an aetiological role in the pathogenesis of polycystic ovary syndrome. Biol Trace Elem Res 152:9\u201315","journal-title":"Biol Trace Elem Res"},{"key":"3433_CR107","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1111\/j.1600-0412.2010.01067.x","volume":"90","author":"RP Kauffman","year":"2011","unstructured":"Kauffman RP, Tullar PE, Nipp RD, Castracane VD (2011) Serum magnesium concentrations and metabolic variables in polycystic ovary syndrome. Acta Obstet Gynecol Scand 90:452\u2013458","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"5","key":"3433_CR108","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1177\/0960327111424299","volume":"31","author":"Z Kurdoglu","year":"2012","unstructured":"Kurdoglu Z, Kurdoglu M, Demir H, Sahin HG (2012) Serum trace elements and heavy metals in polycystic ovary syndrome. Hum Exp Toxicol 31(5):452\u2013456. doi: 10.1177\/0960327111424299","journal-title":"Hum Exp Toxicol"},{"key":"3433_CR109","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1210\/jcem.86.6.7580","volume":"86","author":"CC Kelly","year":"2001","unstructured":"Kelly CC, Lyall H, Petrie JR, Gould GW, Connell JMC, Sattar N (2001) Low grade chronic inflammation in women with polycystic ovary syndrome. J Clin Endocrinol Metab 86:2453\u20132455","journal-title":"J Clin Endocrinol Metab"},{"key":"3433_CR110","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.mrgentox.2005.04.001","volume":"585","author":"RS Slesinski","year":"2005","unstructured":"Slesinski RS, Clarke JJ, San RH, Gudi R (2005) Lack of mutagenicity of chromium picolinate in the hypoxanthine phosphoribosyltransferase gene mutation assay in Chinese hamster ovary cells. Mutat Res 585:86\u201395","journal-title":"Mutat Res"},{"key":"3433_CR111","doi-asserted-by":"crossref","first-page":"2741","DOI":"10.2337\/diacare.27.11.2741","volume":"11","author":"WT Cefalu","year":"2004","unstructured":"Cefalu WT, Hu FB (2004) Role of chromium in human health and in diabetes. Diabetes Care 11:2741\u20132751","journal-title":"Diabetes Care"},{"key":"3433_CR112","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1093\/ajcn\/30.4.531","volume":"30","author":"KN Jeejeebhoy","year":"1977","unstructured":"Jeejeebhoy KN, Chu RC, Marliss EB, Greenberg GR, Bruce-Robertson A (1977) Chromium deficiency, glucose intolerance, and neuropathy reversed by chromium supplementation, in a patient receiving long-term total parenteral nutrition. Am J Clin Nutr 30:531\u2013538","journal-title":"Am J Clin Nutr"},{"key":"3433_CR113","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1080\/07315724.1998.10718801","volume":"17","author":"W Mertz","year":"1998","unstructured":"Mertz W (1998) Chromium research from a distance: from 1959 to 1980. J Am Coll Nutr 17:544\u2013547","journal-title":"J Am Coll Nutr"},{"key":"3433_CR114","doi-asserted-by":"crossref","first-page":"4382","DOI":"10.1021\/bi963154t","volume":"36","author":"CM Davis","year":"1997","unstructured":"Davis CM, Vincent JB (1997) Chromium oligopeptide activates insulin receptor tyrosine kinase activity. Biochemistry 36:4382\u20134385","journal-title":"Biochemistry"},{"key":"3433_CR115","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1080\/07315724.1999.10718821","volume":"18","author":"JB Vincent","year":"1999","unstructured":"Vincent JB (1999) Mechanisms of chromium action: low-molecular-weight chromium-binding substance. J Am Coll Nutr 18:6\u201312","journal-title":"J Am Coll Nutr"},{"key":"3433_CR116","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0946-672X(99)80024-8","volume":"13","author":"BW Morris","year":"1999","unstructured":"Morris BW, MacNeil S, Hardisty CA, Heller S, Burgin C, Gray TA (1999) Chromium homeostasis in patients with type II (NIDDM) diabetes. J Trace Elem Med Biol 13:57\u201361","journal-title":"J Trace Elem Med Biol"},{"key":"3433_CR117","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.fertnstert.2005.11.069","volume":"86","author":"ML Lydic","year":"2006","unstructured":"Lydic ML, McNurlan M, Bembo S, Mitchell L, Komaroff E, Gelato M (2006) Chromium picolinate improves insulin sensitivity in obese subjects with polycystic ovary syndrome. Fertil Steril 86:243\u2013246","journal-title":"Fertil Steril"},{"key":"3433_CR118","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1038\/ki.2010.17","volume":"78","author":"A Verstuyf","year":"2010","unstructured":"Verstuyf A, Carmeliet G, Bouillon R, Mathieu C (2010) Vitamin D: a pleiotropic hormone. Kidney Int 78:140\u2013145","journal-title":"Kidney Int"},{"key":"3433_CR119","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1155\/2010\/351385","volume":"2010","author":"JA Alvarez","year":"2010","unstructured":"Alvarez JA, Ashraf A (2010) Role of vitamin D in insulin secretion and insulin sensitivity for glucose homeostasis. Int J Endocrinol 2010:351\u2013385","journal-title":"Int J Endocrinol"},{"key":"3433_CR120","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.niox.2011.06.005","volume":"25","author":"DT Ngo","year":"2011","unstructured":"Ngo DT, Chan WP, Rajendran S et al (2011) Determinants of insulin responsiveness in young women: impact of polycystic ovarian syndrome, nitric oxide, and vitamin D. Nitric Oxide 25:326\u2013330","journal-title":"Nitric Oxide"},{"key":"3433_CR121","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1046\/j.1464-5491.2003.00971.x","volume":"20","author":"JR Ortlepp","year":"2003","unstructured":"Ortlepp JR, Metrikat J, Albrecht M, von Korff A, Hanrath P, Hoffmann R (2003) The vitamin D receptor gene variant and physical activity predicts fasting glucose levels in healthy young men. Diabet Med 20:451\u2013454","journal-title":"Diabet Med"},{"key":"3433_CR122","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1677\/joe.0.1600087","volume":"160","author":"PM Bourlon","year":"1999","unstructured":"Bourlon PM, Billaudel B, Faure-Dussert A (1999) Influence of vitamin D3 deficiency and 1, 25 dihydroxyvitamin D3 on de novo insulin biosynthesis in the islets of the rat endocrine pancreas. J Endocrinol 160:87\u201395","journal-title":"J Endocrinol"},{"key":"3433_CR123","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1093\/ajcn\/79.5.820","volume":"79","author":"KC Chiu","year":"2004","unstructured":"Chiu KC, Chu A, Go VL, Saad MF (2004) Hypovitaminosis D is associated with insulin resistance and beta cell dysfunction. Am J Clin Nutr 79:820\u2013825","journal-title":"Am J Clin Nutr"},{"key":"3433_CR124","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1111\/j.1365-2265.2012.04434.x","volume":"7","author":"RL Thomson","year":"2012","unstructured":"Thomson RL, Spedding S, Buckley JD (2012) Vitamin D in the aetiology and management of polycystic ovary syndrome. Clin Endocrinol 7:343\u2013350","journal-title":"Clin Endocrinol"},{"key":"3433_CR125","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1007\/BF03350780","volume":"21","author":"R Homburg","year":"1998","unstructured":"Homburg R, Amsterdam A (1998) Polycystic ovary syndrome\u2014loss of the apoptotic mechanism in the ovarian follicles? J Endocrinol Invest 21:552\u2013557","journal-title":"J Endocrinol Invest"},{"key":"3433_CR126","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1210\/jc.2008-1454","volume":"94","author":"D Bikle","year":"2009","unstructured":"Bikle D (2009) Nonclassic actions of vitamin D. J Clin Endocrinol Metab 94:26\u201334","journal-title":"J Clin Endocrinol Metab"},{"key":"3433_CR127","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1053\/j.gastro.2007.03.059","volume":"132","author":"SE Shoelson","year":"2007","unstructured":"Shoelson SE, Herrero L, Naaz A (2007) Obesity, inflammation, and insulin resistance. Gastroenterology 132:2169\u20132180","journal-title":"Gastroenterology"},{"key":"3433_CR128","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1007\/s00404-009-0958-7","volume":"280","author":"R Yildizhan","year":"2009","unstructured":"Yildizhan R, Kurdoglu M, Adali E et al (2009) Serum 25-hydroxyvitamin D concentrations in obese and non-obese women with polycystic ovary syndrome. Arch Gynecol Obstet 280:559\u2013563","journal-title":"Arch Gynecol Obstet"},{"key":"3433_CR129","doi-asserted-by":"crossref","first-page":"965","DOI":"10.3109\/09513590.2012.696753","volume":"28","author":"L Pal","year":"2012","unstructured":"Pal L, Berry A, Coraluzzi L (2012) Therapeutic implications of vitamin D and calcium in overweight women with polycystic ovary syndrome. Gynecol Endocrinol 28:965\u2013968","journal-title":"Gynecol Endocrinol"},{"key":"3433_CR130","first-page":"757","volume":"34","author":"E Wehr","year":"2011","unstructured":"Wehr E, Pieber TR, Obermayer-Pietsch B (2011) Effect of vitamin D3 treatment on glucose metabolism and menstrual frequency in polycystic ovary syndrome women: a pilot study. J Endocrinol Invest 34:757\u2013763","journal-title":"J Endocrinol Invest"},{"key":"3433_CR131","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1007\/BF03345785","volume":"33","author":"H Selimoglu","year":"2010","unstructured":"Selimoglu H, Duran C, Kiyici S, Ersoy C, Guclu M, Ozkaya G, Tuncel E, Erturk E, Imamoglu S (2010) The effect of vitamin D replacement therapy on insulin resistance and androgen levels in women with polycystic ovary syndrome. J Endocrinol Invest 33:234\u2013238","journal-title":"J Endocrinol Invest"},{"key":"3433_CR132","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1210\/jc.2003-030666","volume":"89","author":"SE Kasim-Karakas","year":"2004","unstructured":"Kasim-Karakas SE, Almario RU, Gregory L, Wong R, Todd H, Lasley BL (2004) Metabolic and endocrine effects of a polyunsaturated fatty acid-rich diet in polycystic ovary syndrome. J Clin Endocrinol Metab 89:615\u2013620","journal-title":"J Clin Endocrinol Metab"},{"key":"3433_CR133","doi-asserted-by":"crossref","first-page":"28","DOI":"10.3122\/jabfm.18.1.28","volume":"18","author":"R Oh","year":"2005","unstructured":"Oh R (2005) Practical applications of fish oil (Omega-3 fatty acids) in primary care. J Am Board Fam Pract 18:28\u201336","journal-title":"J Am Board Fam Pract"},{"key":"3433_CR134","doi-asserted-by":"crossref","first-page":"396","DOI":"10.3402\/ijch.v64i4.18016","volume":"64","author":"SO Ebbesson","year":"2005","unstructured":"Ebbesson SO, Risica PM, Ebbesson LO, Kennish JM, Tejero ME (2005) Omega-3 fatty acids improve glucose tolerance and components of the metabolic syndrome in Alaskan Eskimos: the Alaska Siberia project. Int J Circumpolar Health 64:396\u2013408","journal-title":"Int J Circumpolar Health"},{"key":"3433_CR135","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1080\/07315724.2012.10720443","volume":"31","author":"M Rafraf","year":"2012","unstructured":"Rafraf M, Mohammadi E, Asghari-Jafarabadi M, Farzadi L (2012) Omega-3 fatty acids improve glucose metabolism without effects on obesity values and serum visfatin levels in women with polycystic ovary syndrome. J Am Coll Nutr 31:361\u2013368","journal-title":"J Am Coll Nutr"},{"key":"3433_CR136","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1093\/ajcn\/87.2.347","volume":"87","author":"M Kratz","year":"2008","unstructured":"Kratz M, Swarbrick MM, Callahan HS, Matthys CC, Havel PJ, Weigle DS (2008) Effect of dietary n-3 polyunsaturated fatty acids on plasma total and high-molecular-weight adiponectin concentrations in overweight to moderately obese men and women. Am J Clin Nutr 87:347\u2013353","journal-title":"Am J Clin Nutr"},{"issue":"4","key":"3433_CR137","first-page":"511","volume":"21","author":"E Mohammadi","year":"2012","unstructured":"Mohammadi E, Rafraf M, Farzadi L, Asghari-Jafarabadi M, Sabour S (2012) Effects of omega-3 fatty acids supplementation on serum adiponectin levels and some metabolic risk factors in women with polycystic ovary syndrome. Asia Pac J Clin Nutr 21(4):511\u2013518","journal-title":"Asia Pac J Clin Nutr"},{"key":"3433_CR138","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1136\/bmj.39063.689375.55","volume":"334","author":"CL Gillies","year":"2007","unstructured":"Gillies CL, Abrams KR, Lambert PC et al (2007) Pharmacological and lifestyle interventions to prevent or delay type 2 diabetes in people with impaired glucose tolerance: systematic review and meta-analysis. BMJ 334:299","journal-title":"BMJ"},{"key":"3433_CR139","doi-asserted-by":"crossref","first-page":"2282","DOI":"10.1249\/MSS.0b013e3181eeb61c","volume":"42","author":"SR Colberg","year":"2010","unstructured":"Colberg SR, Albright AL, Blissmer BJ et al (2010) Exercise and type 2 diabetes: American College of Sports Medicine and the American Diabetes Association: joint position statement. Exercise and type 2 diabetes. Med Sci Sports Exerc 42:2282\u20132303","journal-title":"Med Sci Sports Exerc"},{"key":"3433_CR140","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1152\/japplphysiol.00053.2005","volume":"99","author":"S Lee","year":"2005","unstructured":"Lee S, Kuk JL, Davidson LE et al (2005) Exercise without weight loss is an effective strategy for obesity reduction in obese individuals with and without Type 2 diabetes. J Appl Physiol 99:1220\u20131225","journal-title":"J Appl Physiol"},{"key":"3433_CR141","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1016\/j.fertnstert.2008.09.018","volume":"92","author":"LJ Moran","year":"2009","unstructured":"Moran LJ, Pasquali R, Teede HJ, Hoeger KM, Norman RJ (2009) Treatment of obesity in polycystic ovary syndrome: a position statement of the Androgen Excess and Polycystic Ovary Syndrome Society. Fertil Steril 92:1966\u20131982","journal-title":"Fertil Steril"},{"key":"3433_CR142","doi-asserted-by":"crossref","first-page":"208","DOI":"10.2337\/dc08-s256","volume":"31","author":"C Bianchi","year":"2008","unstructured":"Bianchi C, Miccoli R, Penno G, Del Prato S (2008) Primary prevention of cardiovascular disease in people with dysglycemia. Diabetes Care 31:208\u2013214","journal-title":"Diabetes Care"},{"key":"3433_CR143","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/j.1365-2265.1992.tb02909.x","volume":"36","author":"DS Kiddy","year":"1992","unstructured":"Kiddy DS, Hamilton-Fairley D, Bush A et al (1992) Improvement in endocrine and ovarian function during dietary treatment of obese women with polycystic ovary syndrome. Clin Endocrinol (Oxf) 36:105\u2013111","journal-title":"Clin Endocrinol (Oxf)"},{"key":"3433_CR144","doi-asserted-by":"crossref","first-page":"2705","DOI":"10.1093\/humrep\/10.suppl_1.31","volume":"10","author":"AM Clark","year":"1995","unstructured":"Clark AM, Ledger W, Galletly C et al (1995) Weight loss results in significant improvement in pregnancy and ovulation rates in anovulatory obese women. Hum Reprod 10:2705\u20132712","journal-title":"Hum Reprod"},{"key":"3433_CR145","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1093\/humrep\/dep101","volume":"24","author":"RL Thomson","year":"2009","unstructured":"Thomson RL, Buckley JD, Moran LJ, Noakes M, Clifton PM, Norman RJ, Brinkworth GD (2009) The effect of weight loss on anti-M\u00fcllerian hormone levels in overweight and obese women with polycystic ovary syndrome and reproductive impairment. Hum Reprod 24:1976\u20131981","journal-title":"Hum Reprod"},{"key":"3433_CR146","first-page":"2586","volume":"80","author":"J Holte","year":"1995","unstructured":"Holte J, Bergh T, Berne C, Wide L, Lithell H (1995) Restored insulin sensitivity but persistently increased early insulin secretion after weight loss in obese women with polycystic ovary syndrome. J Clin Endocrinol Metab 80:2586\u20132593","journal-title":"J Clin Endocrinol Metab"},{"key":"3433_CR147","doi-asserted-by":"crossref","unstructured":"Moran LJ, Hutchison SK, Norman RJ, Teede HJ (2011) Lifestyle changes in women with polycystic ovary syndrome. Cochrane Database Syst Rev 7:CD007506. doi: 10.1002\/14651858.CD007506","DOI":"10.1002\/14651858.CD007506"},{"issue":"4","key":"3433_CR148","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.jand.2012.11.018","volume":"113","author":"LJ Moran","year":"2013","unstructured":"Moran LJ, Ko H, Misso M, Marsh K, Noakes M, Talbot M et al (2013) Dietary composition in the treatment of polycystic ovary syndrome: a systematic review to inform evidence-based guidelines. J Acad Nutr Diet 113(4):520\u2013545. doi: 10.1016\/j.jand.2012.11.018","journal-title":"J Acad Nutr Diet"},{"key":"3433_CR149","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.fertnstert.2005.08.045","volume":"85","author":"CC Douglas","year":"2006","unstructured":"Douglas CC, Gower BA, Darnell BE, Ovalle F, Oster RA, Azziz R (2006) Role of diet in the treatment of polycystic ovary syndrome. Fertil Steril 85:679\u2013688","journal-title":"Fertil Steril"},{"key":"3433_CR150","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1080\/07315724.2012.10720017","volume":"31","author":"HH Mehrabani","year":"2012","unstructured":"Mehrabani HH, Salehpour S, Amiri Z, Farahani SJ, Meyer BJ, Tahbaz F (2012) Beneficial effects of a high-protein, low-glycemic-load hypocaloric diet in overweight and obese women with polycystic ovary syndrome: a randomized controlled intervention study. J Am Coll Nutr 31:117\u2013125","journal-title":"J Am Coll Nutr"},{"key":"3433_CR151","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/j.fertnstert.2013.06.005","volume":"100","author":"SK Graff","year":"2013","unstructured":"Graff SK, M\u00e1rio FM, Alves BC, Spritzer PM (2013) Dietary glycemic index is associated with less favorable anthropometric and metabolic profiles in polycystic ovary syndrome women with different phenotypes. Fertil Steril 100:1081\u20131088","journal-title":"Fertil Steril"},{"key":"3433_CR152","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1038\/ijo.2010.3","volume":"34","author":"HJ Leidy","year":"2010","unstructured":"Leidy HJ, Racki EM (2010) The addition of a protein-rich breakfast and its effects on acute appetite control and food intake in \u2018breakfast-skipping\u2019 adolescents. Int J Obes 34:1125\u20131133","journal-title":"Int J Obes"},{"key":"3433_CR153","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1056\/NEJM198311173092002","volume":"309","author":"B Zumoff","year":"1983","unstructured":"Zumoff B, Freeman R, Coupey S, Saenger P, Markowitz M, Kream J (1983) A chronobiologic abnormality in luteinizing hormone secretion in teenage girls with the polycystic-ovary syndrome. N Engl J Med 309:1206\u20131209","journal-title":"N Engl J Med"},{"key":"3433_CR154","doi-asserted-by":"crossref","first-page":"179","DOI":"10.3109\/09513599309152500","volume":"7","author":"GM Prelevic","year":"1993","unstructured":"Prelevic GM, Wurzburger MI, Balint-Peric L (1993) 24-hour serum cortisol profiles in women with polycystic ovary syndrome. Gynecol Endocrinol 7:179\u2013184","journal-title":"Gynecol Endocrinol"},{"key":"3433_CR155","doi-asserted-by":"crossref","unstructured":"Domecq JP, Prutsky G, Mullan RJ, Hazem A, Sundaresh V, Elamin MB, Phung OJ, Wang A, Hoeger K, Pasquali R, Erwin P, Bodde A, Montori VM, Murad MH (2013) Lifestyle modification programs in polycystic ovary syndrome: Systematic review and meta-analysis. J Clin Endocrinol Metab 98(12):4655\u20134663. doi: 10.1210\/jc.2013-2385","DOI":"10.1210\/jc.2013-2385"},{"key":"3433_CR156","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1249\/MSS.0b013e31818c6c0c","volume":"41","author":"AJ Brown","year":"2009","unstructured":"Brown AJ, Setji TL, Sanders LL, Lowry KP, Otvos JD, Kraus WE, Svetkey PL (2009) Effects of exercise on lipoprotein particles in women with polycystic ovary syndrome. Med Sci Sports Exerc 41:497\u2013504","journal-title":"Med Sci Sports Exerc"},{"key":"3433_CR157","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/S0015-0282(16)56632-1","volume":"61","author":"DS Guzick","year":"1994","unstructured":"Guzick DS, Wing R, Smith D, Berga SL, Winters SJ (1994) Endocrine consequences of weight loss in obese, hyperandrogenic, anovulatory women. Fertility, Sterility 61:598\u2013604","journal-title":"Fertility, Sterility"},{"key":"3433_CR158","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.fertnstert.2004.02.104","volume":"82","author":"KM Hoeger","year":"2004","unstructured":"Hoeger KM, Kochman L, Wixom N, Craig K, Miller RK, Guzick DS (2004) A randomized, 48-week, placebo-controlled trial of intensive lifestyle modification and\/or metformin therapy in overweight women with polycystic ovary syndrome: a pilot study. Fertil Steril 82:421\u2013429","journal-title":"Fertil Steril"},{"key":"3433_CR159","doi-asserted-by":"crossref","first-page":"4299","DOI":"10.1210\/jc.2008-0461","volume":"93","author":"K Hoeger","year":"2008","unstructured":"Hoeger K, Davidson K, Kochman L, Cherry T, Kopin L, Guzick DS (2008) The impact of metformin, oral contraceptives, and lifestyle modification on polycystic ovary syndrome in obese adolescent women in two randomized, placebo-controlled clinical trials. J Clin Endocrinol Metab 93:4299\u20134306","journal-title":"J Clin Endocrinol Metab"},{"key":"3433_CR160","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.fertnstert.2009.02.078","volume":"94","author":"MA Karimzadeh","year":"2010","unstructured":"Karimzadeh MA, Javedani M (2010) An assessment of lifestyle modification versus medical treatment with clomiphene citrate, metformin, and clomiphene citrate-metformin in patients with polycystic ovary syndrome. Fertil Steril 94:216\u2013220","journal-title":"Fertil Steril"},{"key":"3433_CR161","doi-asserted-by":"crossref","first-page":"2783","DOI":"10.1093\/humrep\/deq254","volume":"25","author":"S Palomba","year":"2010","unstructured":"Palomba S, Falbo A, Giallauria F, Russo T, Rocca M, Tolino A, Zullo F, Orio F (2010) Six weeks of structured exercise training and hypocaloric diet increases the probability of ovulation after clomiphene citrate in overweight and obese patients with polycystic ovary syndrome: a randomized controlled trial. Hum Reprod 25:2783\u20132791","journal-title":"Hum Reprod"},{"key":"3433_CR162","first-page":"1694","volume":"28","author":"HS Qublan","year":"2007","unstructured":"Qublan HS, Yannakoula EK, Al-Qudah MA, El-Uri FI (2007) Dietary intervention versus metformin to improve the reproductive outcome in women with polycystic ovary syndrome. A prospective comparative study. Saudi Med J 28:1694\u20131699","journal-title":"Saudi Med J"},{"key":"3433_CR163","doi-asserted-by":"crossref","first-page":"R387","DOI":"10.1152\/ajpregu.00197.2009","volume":"297","author":"E Stener-Victorin","year":"2009","unstructured":"Stener-Victorin E, Jedel E, Janson PO, Sverrisdottir YB (2009) Low-frequency electroacupuncture and physical exercise decrease high muscle sympathetic nerve activity in polycystic ovary syndrome. Am J Physiol Regul Integr Comp Physiol 297:R387\u2013R395","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"3433_CR164","doi-asserted-by":"crossref","unstructured":"Vigorito C, Giallauria F, Palomba S, Cascella T, Manguso F, Lucci R, De Lorenzo A, Tafuri D, Lombardi G, Colao A, Orio F (2007) Beneficial effects of a three-month structured exercise training program on cardiopulmonary functional capacity in young women with polycystic ovary syndrome. J Clin Endocrinol Metab 92:1379\u20131384","DOI":"10.1210\/jc.2006-2794"}],"container-title":["Archives of Gynecology and Obstetrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-014-3433-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00404-014-3433-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-014-3433-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,14]],"date-time":"2019-08-14T19:18:17Z","timestamp":1565810297000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00404-014-3433-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9,9]]},"references-count":164,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["3433"],"URL":"https:\/\/doi.org\/10.1007\/s00404-014-3433-z","relation":{},"ISSN":["0932-0067","1432-0711"],"issn-type":[{"value":"0932-0067","type":"print"},{"value":"1432-0711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,9,9]]}}}